Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Gelesis
gptkb:Karuna_Therapeutics Sonde Health Vedanta Biosciences |
| gptkbp:awards |
Best Places to Work
Innovative_Company_Award |
| gptkbp:CEO |
gptkb:Daphne_Koller
|
| gptkbp:clinicalTrials |
Cancer
Neurological disorders Chronic diseases |
| gptkbp:collaborations |
Academic institutions
Research organizations Healthcare_providers |
| gptkbp:employeeCount |
Over 100
|
| gptkbp:focus |
Innovative therapies
|
| gptkbp:focus_area |
Immunology
Neuroscience Metabolic diseases |
| gptkbp:founded |
2008
|
| gptkbp:founder |
gptkb:Daphne_Koller
|
| gptkbp:headquarters |
gptkb:Boston,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
PureTech
|
| gptkbp:impact |
Global health
Patient outcomes Healthcare_systems |
| gptkbp:industry |
Biotechnology
|
| gptkbp:investmentFocus |
$1 billion
|
| gptkbp:location |
gptkb:Asia
gptkb:North_America Europe |
| gptkbp:mission |
Transforming the treatment of disease
|
| gptkbp:partnerships |
gptkb:AstraZeneca
gptkb:Bristol-Myers_Squibb Novartis |
| gptkbp:philosophy |
Collaborative partnerships
Patient-centric approach Science-driven innovation |
| gptkbp:research |
Clinical trials
Drug development Preclinical studies |
| gptkbp:stockExchange |
PRTC
|
| gptkbp:subsidiary |
gptkb:Gelesis
gptkb:Karuna_Therapeutics Sonde Health Vedanta Biosciences |
| gptkbp:technology |
Biologics
Small molecules Cell therapies |
| gptkbp:type |
Publicly traded company
|
| gptkbp:vision |
Advancing human health
|
| gptkbp:website |
www.puretechhealth.com
|